Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
19 Jun 2014
Lenalidomide versus thalidomide in myeloma
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Lenalidomide versus thalidomide in myeloma ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
19 Jun 2014
Comment: Advances in haematological cancer presented at EHA 2014
Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands
Comment: Advances in haematological cancer presented at EHA 2014 ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )
19 Jun 2014
Advances in mantle cell lymphoma: Expert discussion
Prof Simon Rule and Prof Franco Cavalli
Advances in mantle cell lymphoma: Expert discussion ( Prof Simon Rule and Prof Franco Cavalli )
19 Jun 2014
Advances in chronic lymphocytic leukaemia: Expert panel discussion
Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan
Advances in chronic lymphocytic leukaemia: Expert panel discussion ( Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan )
19 Jun 2014
Genetically modified T cells fight haematological cancer
Dr Roman Galetto - Cellectis Therapeutics, Paris, France
Genetically modified T cells fight haematological cancer ( Dr Roman Galetto - Cellectis Therapeutics, Paris, France )
19 Jun 2014
Pivotal ruxolitinib data shows promise for patients with PV
Prof Alessandro Vannucchi - University of Florence, Florence, Italy
Pivotal ruxolitinib data shows promise for patients with PV ( Prof Alessandro Vannucchi - University of Florence, Florence, Italy )
19 Jun 2014
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
19 Jun 2014
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise...
Dr Zafer Başlar - Istanbul University, Istanbul, Turkey
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety? ( Dr Zafer Başlar - Istanbul University, Istanbul, Turkey )
19 Jun 2014
Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute...
Prof Max Topp - Würzburg University Hospital, Würzburg, Germany
Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )
2 Jun 2014
ASCO 2014 roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Jun 2014
Mantle cell lymphoma: A review of data and expert opinion from ASCO 2014
Prof Franco Cavalli, Prof Gordon McVie
Mantle cell lymphoma: A review of data and expert opinion from ASCO 2014 ( Prof Franco Cavalli, Prof Gordon McVie )
1 Jun 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation